Electroretinogram and Retinal Vascular Changes After Cataract Surgery

Sponsor
Sohag University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05871034
Collaborator
(none)
100
2
18.6

Study Details

Study Description

Brief Summary

To compare electrophysiological and Optical coherence tomography angiography of optic disc and macula changes after uneventful phacoemulsification between normal and cataractus patients with primary open angle glaucoma.

Condition or Disease Intervention/Treatment Phase
  • Procedure: phacoemulsification
N/A

Detailed Description

  • Study design: A prospective, non randomized, interventional, comparative study, control based study.

  • Location: Ophthalmology department, Sohag university hospital. In this prospective study, aiming to investigate Optical coherence tomography angiography and electrophysiological changes after cataract surgery in normal and patients with POAG with cataract 1 day before operation, 1 week and 3 months postoperatively.

  • Methodology The study will include 50 patients with primary open angle glaucoma associated with cataract and 50 patients have cataract without glaucoma.

Preoperative and postoperative evaluation:
All patients will be subjected to the following:
  • History taking including age, gender, family history, systemic diseases, previous medications or ophthalmic surgery.

  • Detailed ophthalmological examination including: Uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA) by Snellen's fraction and converted into logarithm of the minimal angle of resolution LogMAR, refraction, keratometry, slit lamp biomicroscopy for anterior segment, IOP measurement by applanation tonometer, and posterior segment (Fundus) examination.

  • Examination of the angle of anterior chamber by goniolens.

  • OCTA disc and macula

  • Pattern ERG and multifocal ERG

Surgical techniques:
Patients will be subdivided into two groups:
Group (A): normal Patients will undergo standard phacoemulsification surgery. Group (B):

Patients with POAG will undergo standard phacoemulsification surgery.

  • phaco technology by using (WHITESTAR SIGNATURE PRO, Abbott, USA)
  • OCT angiography will be done by (Optovue, Inc., Fremont, California, USA).

  • Electrophysiology will be done by (Roland consult Retimap, Germany)

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Changes of Electrophysiology and Optical Coherence Tomography Angiography in Primary Open Angle Glaucoma After Phacoemulsification
Anticipated Study Start Date :
May 15, 2023
Anticipated Primary Completion Date :
May 15, 2024
Anticipated Study Completion Date :
Dec 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Other: Control group

Control group who have cataract without Open Angle glaucoma Will under go phacoemulsification cataract surgery

Procedure: phacoemulsification
cataract extraction

Other: Open Angle glaucoma group

patients who have cataract and Open Angle glaucoma Will undergo phacoemulsification cataract surgery

Procedure: phacoemulsification
cataract extraction

Outcome Measures

Primary Outcome Measures

  1. Pattern and multifocal electroretinogram and Optical coherence tomography angiography of optic disc and macula changes after phacoemulsification in primary open angle glaucoma [before operation and 1st month, 3rd month post operative]

    electrophysiology and optical coherence tomography angiography changes

Secondary Outcome Measures

  1. Visual acuity and intra ocular pressure changes [before operation and 1st month, 3rd month post operative]

    visual acuity and intraocular pressure changes

Eligibility Criteria

Criteria

Ages Eligible for Study:
45 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients aged: 45-65 years old with cataract density doesn't interfere with Pre-operative imaging (N1-N2).

  • Patients with primary open angle diagnosed for at least 2 years with glaucoma treatment associated with cataract (N1-N2).

Exclusion criteria:

s▪ patient with PACG.

  • Previous intraocular surgery.

  • Associated ocular or intra ocular inflammation

  • Previous history of eye trauma.

  • Associated intraocular pathology

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Sohag University

Investigators

  • Principal Investigator: shorouq abdelrahman, Sohag University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Shorouq Abdelrahman Hassan, Assistant lecturer, Sohag University
ClinicalTrials.gov Identifier:
NCT05871034
Other Study ID Numbers:
  • SAHASSAN
First Posted:
May 23, 2023
Last Update Posted:
May 23, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Shorouq Abdelrahman Hassan, Assistant lecturer, Sohag University
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 23, 2023